Veit Scheble

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

Adam J. Bass, Hideo Watanabe, Craig H. Mermel et al. · Nature Genetics · 2009 · 952 citations · Full text

Medicine, Molecular Biology, Oncology +14

SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer

Theresia Wilbertz, Patrick Wagner, Karen Petersen et al. · Modern Pathology · 2011 · 200 citations · Full text

Medicine, Genetics, Oncology +15

Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma

Claudia Lengerke, Tanja Fehm, Ralf Kurth et al. · BMC Cancer · 2011 · 194 citations · Full text

Life Sciences, Cell Biology, Oncology +9

Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort

Raquel Esgueva, Sven Perner, Christopher J. Lafargue et al. · Modern Pathology · 2010 · 183 citations · Full text

Medicine, Genetics, Urology +11

SOX2 amplification is a common event in squamous cell carcinomas of different organ sites

Sebastian H. Maier, Theresia Wilbertz, Martin Braun et al. · Human Pathology · 2011 · 128 citations

Medicine, Cancer Biology, Oncology +14